
Our mission is to build global brands of research supported pharmaceutical and non-pharmaceutical medical cannabis derived health products.
Company Pillars

GENETICS & VALIDATION
- Proprietary Genetics
- Commercialization Rights
- Medically Validated Strains
- Advanced AG Technology
- Gene Bank Registry
GENETICS & VALIDATION
- Proprietary Genetics
- Commercialization Rights
- Medically Validated Strains
- Advanced AG Technology
- Gene Bank Registry


GENETICS & VALIDATION
- Proprietary Genetics
- Commercialization Rights
- Medically Validated Strains
- Advanced AG Technology
- Gene Bank Registry
About HighBreed Bio Med.

Scientific Solutions for Medical Issues
HighBreed BioMed is focused on developing research supported topical and oral cannabis-based treatments of common ailments and medical conditions, including:
- Psoriasis, eczema and other skin conditions
- Chronic pain
- Diabetes
- Acid reflux
- Kidney stones
Global Reach for Optimal Results
Through its Israeli based subsidiary, Pharmabis Genetics, HBI has significant relationships within the technological and academic communities in Israel, a global leader in agriculture and medical marijuana research and innovation.
In Canada, HBI holds a minority interest in Thrive Cannabis, a cultivation license holder in Ontario, Canada with an existing 10,000 sq. ft. facility and plans for substantial expansion. In addition, through its parent company, HighBreed Corp.
